BETHANY TENNYSON: Open Payments
NPI 1821570482 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 45 payments from 15 companies in 2025. Trend: 2023 $645 · 2024 $703 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $236 |
| Janssen Biotech, Inc. | 6 | $137 |
| PFIZER INC. | 3 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
| GENZYME CORPORATION | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
| Lilly USA, LLC | 2 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $27 |
Products named: TREMFYA, DUPIXENT, LINZESS, SKYRIZI, RINVOQ, XIFAXAN, XELJANZ, ENTYVIO.
Industry payments across AZ — which companies pay providers there.
